Oncology

Oncology drug development is a demanding, complicated and highly competitive area. While there has never been as much opportunity and promise for patients, the challenges to achieve market success are ever increasing.

Therapeutic Experience

Therapeutic Experience

In-depth Expertise

At tranScrip we bring many years of high-end experience in designing and delivering oncology programmes, including targeted treatments, immunotherapies, vaccines, cell-based products and novel cytotoxics.

We are able to help our clients seize opportunities, address challenges and succeed in their drug development or lifecycle management goals by adapting and adopting novel approaches and regulatory pathways.

We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.

Discovery & Preclinical

Set a clear product strategy, define a credible clinical and regulatory path, select the right asset and get ready for first-in-human trials with confidence

Early Clinical​

Implement first-in-human trials, interpreting emerging data and adapting plans as needed. Ensure robust decisions, including clear proof-of-concept

Late Clinical​

Design medically-endorsed pivotal programs that stand up to global regulatory and commercial scrutiny. Navigate issues in implementation​

Registration & Approval

Interpret data, assess benefit/risk and secure regulatory approvals, successfully bring your medicine to market. Ensure strong lifecycle management​

Case Study

Leveraging Phase I Data for a Novel Targeted Oncology Drug

Read more

Brochure

Oncology Project Examples

Read more

“It is with great pleasure and appreciation that we reflect on our 20-year partnership with tranScrip (and previously “Real Regulatory Ltd.” before acquisition by tranScrip). Over the past two decades, their regulatory team has consistently demonstrated a remarkable commitment to excellence, reliability, and professionalism in every project we've undertaken together. Their CTR and regulatory expertise and growing knowledge of Daiichi Sankyo’s internal processes have significantly contributed to our success, and they have always been a dependable partner who understands our needs and surpasses our expectations. This is possible because of very stable and long-term personnel at tranScrip. We also very much appreciate the flexibility and transparency when it comes to resource planning and allocating the appropriate personnel for our dynamic projects.

The collaborative spirit and integrity that tranScrip brings to the table have been instrumental in building a strong, long-lasting relationship based on trust and mutual respect. Their dedication to quality, flexibility and timely delivery has been unwavering, earning them our highest recommendation.

We look forward to many more years of successful collaboration and continued achievements. Thank you, tranScrip, for being an exceptional partner in our journey.”

Bettina Steffens

Director Regulatory Affairs

Daiichi Sankyo Europe GmbH

Contact Us

Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.